Abstract
The study was designed to assess the hepatitis B virus and hepatitis C virus prevalence in HIV infected patients in tertiary care hospitals. A cross sectional study of prevalence and risk factors of HBV and HCV co-infection in HIV patients was conducted. A total of 1716 patients of all ages enrolled for ART Therapy at ART centre were screened for the presence of HBs Ag and anti-HCV antibodies by ELISA technique. In 1716 HIV infected patients, 56(3.26%) were positive for HBV and 16(0.9%) for HCV and 1(0.05%) was positive for dual co-infection (HBV/HCV). Heterosexual contact were the acquisition of HBV/HIV co-infection in 75% of patients and other modes like MSM 1.78%, Injective drug users 5.35%, Blood transfusion 1.78%, Mother to child 3.57%, Probable unsafe injection 1.4%, unknown 8.92%, commercial sex worker 0% while in HCV/HIV co-infection 50% acquisition is by heterosexual contact and second most common risk factor was injective drug users 43.7% in seropositive patients. The principal routes for HIV transmission are similar to HBV and HCV infection. In our study the heterosexual contact and Injective drug users were found to be major risk groups. The prevalence of HBV and HCV is low among HIV patients in Allahabad as compared to other studies of North India. However it would be advisable to screen for these viruses in all the HIV infected individuals and their sexual partners at the earliest.
Key words: Seroprevalence, HBV, HCV, HBV HCV India, co-infection, HIV.
References
1. Leeratanaptech N, Suseangrut W Hepatitis B Virus and Hepatitis C Virus Co-infection with HIV patients at KhonKean Hospital. Khankaen Hospital Medical Journal 2008,32:229-23
2. Modi A A, Feld J J Viral Hepatitis and HIV in America. AIDS Rev 2007, 9:25-39.
3. Mohammad M, Talel G, Sheikhian A et al. Survey of both hepatitis B virus (HBs Ag) and hepatitis C virus (HCV-Ab) co-infection among HIV positive patients. Virology journal 2009;6:202
4. Pouti M, Torti C, Bruno R, Filice G, et al. Natural history of chronic hepatitis B in co-infected patients. J of Hepatol, 4: S 65–70 (2006).
5. Thio C. Hepatitis B and HIV co-infection. J of Hepatol, 49: S 138 – 45 (2009)
6. Gatanga H, Yasuoka A, Kikuchi Y, Tachikawa N, Oka S. Influence of prior HIV 1 infection on the development of chronic hepatitis B infection. Eur J Clin Microbiol Infect Dis, 19: 237 – 9 (2000).
7. Sonia Nagy G. Mortality in HIV/HBV co-infection in the multicentre AIDS cohort study (MACS). AIDS clinical care2003; 301-305.
8. Amin J. HIV and Hepatitis C co-infection with in the CAESAR study. HIV Med 2004; 5:174- 179.
9. Dhanvijay AG, Thakar YS, Chande CA. Hepatitis B infection in HIV infected patients. IJMM 1999; 17: 167-9.
10. Saha ML, Chakrabarty S, Panda S, et al. Prevalence of HIV and HBV infection amongst HIV seropositive intravenous drug users in Manipur in India. Indian I Med Res 2000; III: 37-9.
11. Jose P. Augustine .Study of Hepatitis B Virus and Hepatitis C Virus Co-infection in Human Immunodeficiency Virus Seropositive Cases. International Journal of Recent Trends in Science And Technology, ISSN 2277-2812 E-ISSN 2249-8109, Volume 10, Issue 3, 2014 pp 416-420.
12. S. Sood and S. Malvankar, Seroprevalance of Hepatitis B surface Antigen ,antibodies to the Hepatitis C virus, and Human immunodeficiency virus in a hospital–based population in Jaipur ,Rajasthan, Indian Journal of Community Medicine ,vol.35,no.1,pp.165-169,2010.
13. Sumit Gayat, Gujinder Singh et al Prevalance of Hepatitis B and Hepatitis C virus Coinfection in HIV Positive patients from Tertiary care hospital in Patiala District of Northern India
14. Sanjiv Ahuja, Shalini Malhotra , Ankit Chauhan et al: Seroprevalance of Hepatitis B and C co-infection in HIV Positive patients from a Tertiary Care Hospital. JIMSA April –June 2013 Vol.26 No.2
15. AK Tripathi, M Khanna, N Gupta, M Chandra. Lowprevalence of Hepatitis B virus and Hepatitis C virus coinfection in patients with Human Immunodeficiency Virus in Northern India. Indian J. of medical research 2006
DOI: http://dx.doi.org/10.18535/jmscr/v3i10.12
